Alaarag AF, Hamam AM, Amin OA. The Safety of The Directly Acting Antiviral Treatment For Hepatitis C Virus According To The Egyptian National Program Protocol In Patients With Midrange Ejection Fraction. Glob Heart 2021;16:3. [PMID: 33598383 DOI: 10.5334/gh.906][Cited by in Crossref: 1][Article Influence: 1.0][Reference Citation Analysis]
3
Roguljic H, Nincevic V, Bojanic K, Kuna L, Smolic R, Vcev A, Primorac D, Vceva A, Wu GY, Smolic M. Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update. Front Pharmacol 2021;12:678546. [PMID: 34045969 DOI: 10.3389/fphar.2021.678546][Reference Citation Analysis]
4
Terlapu PV, Gedela SB, Gangu VK, Pemula R. Intelligent diagnosis system of hepatitis C virus: A probabilistic neural network based approach. Int J Imaging Syst Tech. [DOI: 10.1002/ima.22746][Reference Citation Analysis]